Finance / INSM (Insmed, Inc.)

Insmed to Participate in Federal Trade Commission Roundtable on Follow-on Biologic Drugs: Framework for Competition and Continued Innovation Insmed Inc. (Nasdaq: INSM - News) a developer of follow-on biologics and biopharmaceuticals, today announced that Geoffrey Allan, Ph.D., CEO of Insmed, will participate in the Federal Trade Commission Roundtable on Follow-on Biologic Drugs: Framework for ...

Beacon Equity Issues Technical Trade Alerts on Market Movers: ASTM, BRCD, DPTR, GERN, SWHC, INSM Date : 11/11/2008 @ 9:00AM Source : PR Newswire Stock : Smith & Wesson Holding (MM) (SWHC) Quote : 2.91 0.0 (0.00%) @ 9:07AM Beacon Equity Issues Technical Trade Alerts on Market Movers: ASTM, BRCD, DPTR, GERN, SWHC, INSM DALLAS, Nov. 11 /PRNewswire/ -- BeaconEquity.com announces the availability of ...

  Recs: 1 Schwab Picks Us Up Just got in my account.  INSM went from NC (Not Covered) to covered with a C rating.   Schwab Equity Rating Important Changes on Insmed Inc (INSM:NASDAQ) C Marketperform Summary On November 9, 2008, the Schwab Equity Rating (SER) was changed to C from NC. This Week's Rating...

  Recs: 0 OT INSM will deliver iplex for ALS in named patient programs - agreement with Genentech/Ipsen will follow on positive EAP data Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs Monday November 10, 8:00 am ET RICHMOND, Va., Nov. 10 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM - News...

[INSM] Agreement on iplex for ALS in named patient programs - agreement with Genentech/Ipsen will follow on positive EAP data Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs Monday November 10, 8:00 am ET RICHMOND, Va., Nov. 10 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM - News), a developer of follow-...

  Recs: 2 OT OT INSM will deliver iplex for ALS in named patient programs - agreement with Genentech/Ipsen will follow on positive EAP data Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs Monday November 10, 8:00 am ET RICHMOND, Va., Nov. 10 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM - ...

  Recs: 2 OT INSM will deliver iplex for ALS in named patient programs - agreement with Genentech/Ipsen will follow on positive EAP data Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs Monday November 10, 8:00 am ET RICHMOND, Va., Nov. 10 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM - News...

PR out - it's official - Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs * Monday November 10, 2008, 8:00 am EST * Yahoo! Buzz Related: * insm RICHMOND, Va., Nov. 10 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM - News), a developer of follow-on biologics and biopharmaceuticals, today ...

  Recs: 4 Insmed to Present at Upcoming Healthcare Conferences Insmed to Present at Upcoming Healthcare Conferences Wednesday November 5, 8:00 am ET RICHMOND, Va., Nov. 5 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM - News), a developer of follow-on biologics and biopharmaceuticals, announced today that Dr. Geoffrey Allan, President and CEO of Insmed, and Steve...